- Exchange: ASE
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Starpharma Holdings Ltd+ Add to Watchlist
SPL:AU0.8700 AUD 0.0050 0.58%
As of 02:10:37 ET on 05/24/2013.
Company Profile for Starpharma Holdings Ltd (SPL)
Starpharma Holdings Limited is biotechnology company involved in the research, development and commercialization of dendrimer-based for pharmaceutical, life sciences and other applications. The Company's lead product in development is VivaGel, a microbicide gel for women, for the prevention and treatment of bacterial vaginosis adn a range of sexually transmitted diseases.
Starpharma Holdings Ltd
Key Executives for Starpharma Holdings Ltd (SPL)
|Jacinth K Fairley "Jackie"CEO/Executive Director||Nigel J BaadeChief Financial Officer|
|C Paul BarrettVP:Business Development||Jeremy R PaullVP:Dev & Regulatory Affairs|
|David J OwenVP:Research||Ben P RogersSecretary|